Showing 1 - 10 of 38
Persistent link: https://www.econbiz.de/10002570664
EU Merger Control Regulation No 4064/89 tended to rely on a dominance test, based on the market share of undertakings, to indicate the level and potential changes in market power. The use of such in differentiated product industries is questionable. New EC Merger Regulation No 139/2004...
Persistent link: https://www.econbiz.de/10002401642
Persistent link: https://www.econbiz.de/10003342296
Persistent link: https://www.econbiz.de/10003258101
Persistent link: https://www.econbiz.de/10001905546
We examine industrial output in Bulgaria, Hungary, Poland, and Romania during 1989–95 in terms of pretransitional product trade orientation. The growth of EU-oriented output within sectors of industry, ex-post trade, and market liberalization, is modeled as foreign direct investment induced...
Persistent link: https://www.econbiz.de/10014403410
The price effect of past mergers has been extensively researched over the last two decades. The overwhelming majority of these studies pool post-merger data to estimate the average price effect of a merger. Merger guidelines agree that mergers should be approved if market dynamics, such as...
Persistent link: https://www.econbiz.de/10012969257
This paper finds evidence of an inverse U shape in the number of cartels detected by a Competition Agency (CA) over its lifetime. We interpret this as evidence that, as the CA builds up experience in enforcement, this feeds back into the business community to deter future cartel formation. We...
Persistent link: https://www.econbiz.de/10012953394
An overwhelming stream of research suggests that online reviews impact firms' profits positively. In this study, we show conditions where this may not hold true. In a vertical market, we identify strategies that a manufacturer can utilize to affect a retailer's attitude towards publicizing...
Persistent link: https://www.econbiz.de/10012955813
New drug introductions are a key to growth for pharmaceutical firms. However not all innovations are the same and they may have differential effects that vary by firm size. We use quarterly sales data on UK pharmaceuticals in a dynamic panel model to estimate the impact of product (new drugs)...
Persistent link: https://www.econbiz.de/10012903446